Authors:
Kaikita, K
Fogo, AB
Ma, LJ
Schoenhard, JA
Brown, NJ
Vaughan, DE
Citation: K. Kaikita et al., Plasminogen activator inhibitor-1 deficiency prevents hypertension and vascular fibrosis in response to long-term nitric oxide synthase inhibition, CIRCULATION, 104(7), 2001, pp. 839-844
Authors:
Soejima, H
Ogawa, H
Suefuji, H
Kaikita, K
Takazoe, K
Miyamoto, S
Kajiwara, I
Shimomura, H
Sakamoto, T
Yoshimura, M
Nakamura, S
Citation: H. Soejima et al., Comparison of effects of losartan versus enalapril on fibrinolysis and coagulation in patients with acute myocardial infarction, AM J CARD, 87(12), 2001, pp. 1408-1411
Authors:
Ogawa, H
Sakamoto, T
Nishiyama, K
Soejima, H
Kaikita, K
Takazoe, K
Miyamoto, S
Kugiyama, K
Yoshimura, M
Yasue, H
Citation: H. Ogawa et al., Elevated levels of soluble intercellular adhesion molecule-1 in the coronary circulation of patients with coronary organic stenosis and spasm, JPN CIRC J, 64(3), 2000, pp. 170-176
Authors:
Ogawa, H
Suefuji, H
Takazoe, K
Soejima, H
Sakamoto, T
Miyamota, S
Kaikita, K
Yoshimura, M
Kugiyama, K
Yasue, H
Citation: H. Ogawa et al., Difference in fibrinolytic activity between multivessel coronary spasm andone-vessel coronary spasm, AM J CARD, 85(1), 2000, pp. 98
Authors:
Soejima, H
Ogawa, H
Yasue, H
Kaikita, K
Takazoe, K
Nishiyama, K
Misumi, K
Miyamoto, S
Yoshimura, M
Kugiyama, K
Nakamura, S
Tsuji, I
Citation: H. Soejima et al., Angiotensin-converting enzyme inhibition reduces monocyte chemoattractant protein-1 and tissue factor levels in patients with myocardial infarction, J AM COL C, 34(4), 1999, pp. 983-988
Authors:
Takazoe, K
Ogawa, H
Yasue, H
Sakamoto, T
Oshima, S
Arai, H
Moriyama, Y
Shimomura, H
Hirai, N
Kaikita, K
Soejima, H
Misumi, K
Hosoda, K
Citation: K. Takazoe et al., Association of plasma levels of activated protein C with recanalization ofthe infarct-related coronary artery after thrombolytic therapy in acute myocardial infarction, THROMB RES, 95(1), 1999, pp. 37-47
Authors:
Soejima, H
Ogawa, H
Yasue, H
Nishiyama, K
Kaikita, K
Misumi, K
Takazoe, K
Kugiyama, K
Tsuji, I
Kumeda, K
Nakamura, S
Citation: H. Soejima et al., Plasma tissue factor pathway inhibitor and tissue factor antigen levels after administration of heparin in patients with angina pectoris, THROMB RES, 93(1), 1999, pp. 17-25
Authors:
Kaikita, K
Takeya, M
Ogawa, H
Suefuji, H
Yasue, H
Takahashi, K
Citation: K. Kaikita et al., Co-localization of tissue factor and tissue factor pathway inhibitor in coronary atherosclerosis, J PATHOLOGY, 188(2), 1999, pp. 180-188
Authors:
Soejima, H
Ogawa, H
Yasue, H
Kaikita, K
Nishiyama, K
Misumi, K
Takazoe, K
Miyao, Y
Yoshimura, M
Kugiyama, K
Nakamura, S
Tsuji, I
Kumeda, K
Citation: H. Soejima et al., Heightened tissue factor associated with tissue factor pathway inhibitor and prognosis in patients with unstable angina, CIRCULATION, 99(22), 1999, pp. 2908-2913
Authors:
Ogawa, H
Yasue, H
Miyao, Y
Sakamoto, T
Soejima, H
Nishiyama, K
Kaikita, K
Suefuji, H
Misumi, K
Takazoe, K
Kugiyama, K
Yoshimura, M
Citation: H. Ogawa et al., Plasma soluble intercellular adhesion molecule-1 levels in coronary circulation in patients with unstable angina, AM J CARD, 83(1), 1999, pp. 38-42